NSCLC tumor shrinkage prediction using quantitative image features

The objective of this study was to develop a quantitative image feature model to predict non-small cell lung cancer (NSCLC) volume shrinkage from pre-treatment CT images. 64 stage II-IIIB NSCLC patients with similar treatments were all imaged using the same CT scanner and protocol. For each patient, the planning gross tumor volume (GTV) was deformed onto the week 6 treatment image, and tumor shrinkage was quantified as the deformed GTV volume divided by the planning GTV volume. Geometric, intensity histogram, absolute gradient image, co-occurrence matrix, and run-length matrix image features were extracted from each planning GTV. Prediction models were generated using principal component regression with simulated annealing subset selection. Performance was quantified using the mean squared error (MSE) between the predicted and observed tumor shrinkages. Permutation tests were used to validate the results. The optimal prediction model gave a strong correlation between the observed and predicted tumor shrinkages with r=0.81 and MSE=8.60×10(-3). Compared to predictions based on the mean population shrinkage this resulted in a 2.92 fold reduction in MSE. In conclusion, this study indicated that quantitative image features extracted from existing pre-treatment CT images can successfully predict tumor shrinkage and provide additional information for clinical decisions regarding patient risk stratification, treatment, and prognosis.

[1]  O. Mawlawi,et al.  Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. , 2014, International journal of radiation oncology, biology, physics.

[2]  Joe Y. Chang,et al.  Validation of an accelerated ‘demons’ algorithm for deformable image registration in radiation therapy , 2005, Physics in medicine and biology.

[3]  Haesun Choi,et al.  Response evaluation of gastrointestinal stromal tumors. , 2008, The oncologist.

[4]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[5]  R. Mohan,et al.  HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[6]  M. Shackcloth,et al.  Lung cancer staging: a physiological update. , 2012, Interactive cardiovascular and thoracic surgery.

[7]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[8]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[9]  Q. Wei,et al.  Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy , 2010, BMC Cancer.

[10]  I. Jolliffe A Note on the Use of Principal Components in Regression , 1982 .

[11]  C. Jaffe Measures of response: RECIST, WHO, and new alternatives. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Brandon Whitcher,et al.  Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps , 2009, Magnetic resonance in medicine.

[13]  R. F. Ling,et al.  Some cautionary notes on the use of principal components regression , 1998 .

[14]  Q. Wei,et al.  Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy , 2012, Cancer.

[15]  Radhe Mohan,et al.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.

[16]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[17]  Osama Mawlawi,et al.  Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors. , 2016, Radiology.

[18]  Kari Chansky,et al.  The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[19]  Satrajit Basu Developing Predictive Models for Lung Tumor Analysis , 2012 .

[20]  L. Turnbull,et al.  Textural analysis of contrast‐enhanced MR images of the breast , 2003, Magnetic resonance in medicine.

[21]  Mary M. Galloway,et al.  Texture analysis using gray level run lengths , 1974 .

[22]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[23]  Jinzhong Yang,et al.  IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. , 2015, Medical physics.